Alkem Laboratories Limited (ALKEM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.061x

Based on the latest financial reports, Alkem Laboratories Limited (ALKEM) has a cash flow conversion efficiency ratio of 0.061x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs8.37 Billion ≈ $90.47 Million USD) by net assets (Rs138.11 Billion ≈ $1.49 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Alkem Laboratories Limited for the company's overall valuation and market capitalisation.

Alkem Laboratories Limited - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Alkem Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Alkem Laboratories Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alkem Laboratories Limited ranked by their cash flow conversion efficiency. Explore Alkem Laboratories Limited cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Cipher Mining Inc NASDAQ:CIFR	-0.414x
Hyundai Autoever Corp KO:307950	0.025x
Jiangsu Expressway Co Ltd SHG:600377	0.046x
Light & Wonder Inc NASDAQ:LNW	0.254x
Bank of Maharashtra NSE:MAHABANK	-0.678x
Element Fleet Management Corp TO:EFN	0.190x
Cleveland-Cliffs Inc NYSE:CLF	0.040x
Etsy, Inc. NYSE:ETSY	-0.071x

Annual Cash Flow Conversion Efficiency for Alkem Laboratories Limited (2010–2025)

The table below shows the annual cash flow conversion efficiency of Alkem Laboratories Limited from 2010 to 2025. View ALKEM share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs124.34 Billion ≈ $1.34 Billion	Rs19.13 Billion ≈ $206.87 Million	0.154x	-15.39%
2024-03-31	Rs107.14 Billion ≈ $1.16 Billion	Rs19.48 Billion ≈ $210.68 Million	0.182x	+1.96%
2023-03-31	Rs94.35 Billion ≈ $1.02 Billion	Rs16.82 Billion ≈ $181.96 Million	0.178x	+42.00%
2022-03-31	Rs88.47 Billion ≈ $956.81 Million	Rs11.11 Billion ≈ $120.15 Million	0.126x	-24.97%
2021-03-31	Rs75.58 Billion ≈ $817.37 Million	Rs12.65 Billion ≈ $136.79 Million	0.167x	+80.46%
2020-03-31	Rs63.09 Billion ≈ $682.29 Million	Rs5.85 Billion ≈ $63.27 Million	0.093x	-33.53%
2019-03-31	Rs55.72 Billion ≈ $602.59 Million	Rs7.77 Billion ≈ $84.07 Million	0.140x	+151.85%
2018-03-31	Rs49.85 Billion ≈ $539.14 Million	Rs2.76 Billion ≈ $29.87 Million	0.055x	-46.11%
2017-03-31	Rs45.83 Billion ≈ $495.62 Million	Rs4.71 Billion ≈ $50.95 Million	0.103x	-46.36%
2016-03-31	Rs37.87 Billion ≈ $409.55 Million	Rs7.26 Billion ≈ $78.50 Million	0.192x	+81.66%
2015-03-31	Rs30.85 Billion ≈ $333.60 Million	Rs3.25 Billion ≈ $35.20 Million	0.106x	-3.41%
2014-03-31	Rs26.55 Billion ≈ $287.14 Million	Rs2.90 Billion ≈ $31.37 Million	0.109x	+65.86%
2013-03-31	Rs23.74 Billion ≈ $256.72 Million	Rs1.56 Billion ≈ $16.91 Million	0.066x	+5.93%
2012-03-31	Rs19.06 Billion ≈ $206.08 Million	Rs1.18 Billion ≈ $12.81 Million	0.062x	-91.34%
2011-03-31	Rs11.67 Billion ≈ $126.25 Million	Rs8.38 Billion ≈ $90.62 Million	0.718x	+1128.81%
2010-03-31	Rs12.05 Billion ≈ $130.35 Million	Rs-840.93 Million ≈ $-9.09 Million	-0.070x	--

About Alkem Laboratories Limited

NSE:ALKEM India Drug Manufacturers - Specialty & Generic

Market Cap

$7.01 Billion

Rs647.74 Billion INR

Market Cap Rank

#2891 Global

#128 in India

Share Price

Rs5417.50

Change (1 day)

+1.61%

52-Week Range

Rs5087.50 - Rs5890.00

All Time High

Rs6366.25